企業プロフィール
Cardiol Therapeutics Inc 株価・ニュース・カタリスト
- ティッカー:
- CRDL
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- Canada and listed in the U
株価パフォーマンス
1.80 USD (0.00%)
終値
最終更新: 2026年8月17日
133M USD
時価総額
株価変動の要因
As of Aug 17, 2026, CRDL was little changed and closed at $1.80. No new same-company headline was identified in the current news window.
企業概要
事業概要
Cardiol Therapeutics is a biotechnology company focused on inflammatory heart disease and cardiology-related immunology. Its story centers on whether anti-inflammatory approaches can improve cardiac outcomes in a focused setting.
所在地とセクター分類
Cardiol Therapeutics is headquartered in Canada and listed in the U.S. market. It sits in specialty cardiology biotechnology.
ビジネスモデルの特徴
The company depends on clinical data, translational confidence, and the ability to keep a narrow cardiovascular pipeline moving. Investors watch efficacy, safety, and proof-of-concept work.
バイオ業界での位置付け
Cardiol occupies a specialized cardio-immunology niche within biotech. The stock is catalyst-sensitive because the market needs evidence that the platform can matter in cardiac disease.
今後のカタリスト
- CRDL is a small-cap biotech / diagnostics name with catalysts around product and pipeline updates, plus any strategic step that clarifies the company's direction. The market will care about whether there is still a viable growth path.
最近のニュース
- 01
- 02
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。